Pradžia › Geltonosios dėmės edema › Florida
Geltonosios dėmės edema klinikiniai tyrimai Florida
5 tyrimai dėl Geltonosios dėmės edema ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Retina Group of Florida - Fort Lauderdale Retina Center, Fort Lauderdale
- Florida Retina Institute, Jacksonville Southside, Jacksonville
- Advanced Research Institute, Pompano Beach
- ir dar 2
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06962839A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Retina Vitreous Associates of Florida ( Site 0034), Tampa
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Center for Retina and Macular Disease ( Site 0047), Winter Haven
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07705607A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
- Florida Eye Clinic, Altamonte Springs
- Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale
- Retina Vitreous Associates of Florida (St. Petersburg), St. Petersburg
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-18 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
- Florida Eye Clinic, Altamonte Springs
- Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale
- Retina Vitreous Associates of Florida (St. Petersburg), St. Petersburg
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-18 · NCT06996080Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.